Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

316.17
Delayed Data
As of 4:00pm ET
 +4.17 / +1.34%
Today’s Change
310.51
Today|||52-Week Range
543.55
-15.90%
Year-to-Date

Today’s Trading

Previous close312.00
Today’s open312.00
Day’s range311.04 - 321.23
Volume661,669
Average volume (3 months)874,044
Market cap$36.8B
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+34.29%
Earnings growth (this year)+12.53%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+20.82%
P/E ratio30.6
Price/Sales7.42
Price/Book5.99

Competitors

 Today’s
change
Today’s
% change
SHPGShire-5.56-3.39%
VRTXVertex Pharmaceutica...-0.52-0.33%
BAXBaxter International...+0.37+0.56%
ALXNAlexion Pharmaceutic...-0.47-0.44%
Data as of 4:15pm ET, 04/25/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$3.85
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts